Dechra Pharmaceuticals Future Growth
Future criteria checks 4/6
Dechra Pharmaceuticals is forecast to grow earnings and revenue by 62.5% and 7.9% per annum respectively. EPS is expected to grow by 89.8% per annum. Return on equity is forecast to be 19.8% in 3 years.
Key information
62.5%
Earnings growth rate
89.8%
EPS growth rate
| Pharmaceuticals earnings growth | 19.6% |
| Revenue growth rate | 7.9% |
| Future return on equity | 19.8% |
| Analyst coverage | Low |
| Last updated | 03 Jan 2024 |
Recent future growth updates
Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 954 | 187 | N/A | N/A | 1 |
| 6/30/2025 | 904 | 123 | 160 | 182 | 5 |
| 6/30/2024 | 837 | 102 | 142 | 163 | 2 |
| 6/30/2023 | 762 | -28 | 33 | 64 | N/A |
| 3/31/2023 | 744 | 6 | 39 | 75 | N/A |
| 12/31/2022 | 727 | 40 | 45 | 86 | N/A |
| 9/30/2022 | 704 | 49 | 45 | 105 | N/A |
| 6/30/2022 | 682 | 58 | 45 | 123 | N/A |
| 3/31/2022 | 661 | 66 | 48 | 121 | N/A |
| 12/31/2021 | 641 | 73 | 51 | 119 | N/A |
| 9/30/2021 | 624 | 64 | 3 | 104 | N/A |
| 6/30/2021 | 608 | 56 | -45 | 89 | N/A |
| 3/31/2021 | 587 | 50 | -45 | 102 | N/A |
| 12/31/2020 | 566 | 44 | -44 | 114 | N/A |
| 9/30/2020 | 541 | 39 | 7 | 110 | N/A |
| 6/30/2020 | 515 | 34 | 57 | 106 | N/A |
| 3/31/2020 | 507 | 31 | 57 | 91 | N/A |
| 12/31/2019 | 499 | 29 | 57 | 76 | N/A |
| 9/30/2019 | 490 | 30 | 58 | 79 | N/A |
| 6/30/2019 | 482 | 31 | 59 | 82 | N/A |
| 3/31/2019 | 463 | 28 | 61 | 82 | N/A |
| 12/31/2018 | 444 | 25 | 62 | 81 | N/A |
| 9/30/2018 | 426 | 30 | 57 | 73 | N/A |
| 6/30/2018 | 407 | 36 | 51 | 64 | N/A |
| 3/31/2018 | 394 | 40 | 57 | 69 | N/A |
| 12/31/2017 | 381 | 43 | 63 | 75 | N/A |
| 9/30/2017 | 370 | 35 | 65 | 76 | N/A |
| 6/30/2017 | 359 | 26 | 67 | 77 | N/A |
| 3/31/2017 | 334 | 19 | N/A | 69 | N/A |
| 12/31/2016 | 309 | 11 | N/A | 62 | N/A |
| 9/30/2016 | 278 | 12 | N/A | 53 | N/A |
| 6/30/2016 | 248 | 13 | N/A | 44 | N/A |
| 3/31/2016 | 230 | 17 | N/A | 43 | N/A |
| 12/31/2015 | 213 | 20 | N/A | 42 | N/A |
| 9/30/2015 | 208 | 20 | N/A | 42 | N/A |
| 6/30/2015 | 203 | 19 | N/A | 41 | N/A |
| 3/31/2015 | 201 | 21 | N/A | 41 | N/A |
| 12/31/2014 | 199 | 22 | N/A | 42 | N/A |
| 9/30/2014 | 196 | 21 | N/A | 27 | N/A |
| 6/30/2014 | 194 | 19 | N/A | 11 | N/A |
| 12/31/2013 | 193 | 14 | N/A | 25 | N/A |
| 9/30/2013 | 191 | 13 | N/A | 31 | N/A |
| 6/30/2013 | 189 | 11 | N/A | 37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: DPH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DPH is expected to become profitable in the next 3 years.
Revenue vs Market: DPH's revenue (7.9% per year) is forecast to grow faster than the UK market (3.8% per year).
High Growth Revenue: DPH's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DPH's Return on Equity is forecast to be low in 3 years time (19.8%).